All News about Catalent IncVia Benzinga
Catalent-Repligen Merger 'Seems Unlikely,' This Analyst Says
August 12, 2022
Via Benzinga
Catalent, Inc. Reports Fourth Quarter Fiscal 2022 Results
August 29, 2022
From Catalent, Inc.
Via Business Wire
Why Erytech Pharma Are Shares Moving Higher Today
April 25, 2022
Via Benzinga
From Catalent, Inc.
Via Business Wire
Via Benzinga
From Catalent, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|